|
|
Blood, Vol. 109, Issue 9, 4023-4027, May 1, 2007

Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia
Blood Asou et al.
109: 4023
Supplemental materials for: Asou et al, Vol 109, Issue 9, 4023-4027
Files in this Data Supplement:
- Figure S1. Specificity of AML1, AML1-TRPS1, or TRPS1 binding to the AML1 or GATA site (PDF, 45.2 KB) -
(A) Sequence-specific binding of AML1 and AML1-TRPS1 to the AML1 site. Whole-cell extracts of COS7 cells transfected with the expression vectors for AML1 and AML1-TRPS1 were subjected to EMSA. All lanes, except for the end left lane (–), were supplemented with a 50-fold molar excess of mutant probe (M) to eliminate the non-specific band indicated by the asterisk. The binding of AML1 or AML1-TRPS1 was competed out by 50-fold molar excess of unlabeled wild type competitor (lanes M+C). The sequences of the wild-type and mutant probes for the AML1 site have been described previously.12 (B-C) Specificity of GATA-1, AML1-TRPS1 and TRPS1 binding to the GATA site. Whole-cell extracts of COS7 cells transfected with the expression vectors for GATA-1, AML1-TRPS1, or FLAG-tagged TRPS1 (FL-TRPS1) were subjected to EMSA. The binding of these 3 factors to the GATA probe lanes (–) was competed out by a 50-fold molar excess amount of unlabeled wild-type competitor (C), but not by the 50-fold molar excess of mutant probe (M), in both panels B and C. The sequences of the wild-type and mutant probes for GATA1 were 5′-ctggggacagataagctacagc-3′, and 5′-ctggggacagacaagctacagc-3′, respectively. The GATA site is underlined. The FL-TRPS1 and DNA complex was supershifted in the presence of anti-FLAG antibody (M2 monoclonal antibody; Sigma) (C; lane Ab).
- Figure S2. AML1 or GATA site-dependent activation of pBXH2-luc or pRBGP3-MαP reporter (PDF, 24.8 KB) -
(A) AML1 site-dependent activation of pBXH2-LTR-luc reporter. AML1 and AML1-TRPS1 were cotransfected with pBXH2-LTR-luc or mutant pBXH2-LTR-luc (Mut LTR) reporters, at the indicated doses, into HL-60 cells. Luciferase activity is expressed as fold changes relative to the control. The Mut LTR reporter carrying AML1 site mutation was generated by PCR-based mutagenesis using 5′-aacaggatatgtgtCgtcaagcactagggc-3′ as a primer. The substituted nucletotide in the AML1 site underlined is capitalized. (B) Repression of GATA-1–mediated transcription by TRPS1 per se. GATA-1, AML1-TRPS1, or FLAG-tagged TRPS1 (FL-TRPS1) were cotransfected with M P or mutant M P (Mut M P) reporters at the indicated doses, into NIH3T3 cells. Luciferase activity is expressed as fold changes relative to the control. Repression of GATA-1–mediated transcription by TRPS1 was statistically significant (P = .007, unpaired student t test). Protein expression level of FL-TRPS1 and AML1-TRPS1 is shown in the lower panel. Western blotting was carried out using goat polyclonal anti-TRPS1 antibody (N-18; Santa Cruz Biotechnology). Since the protein expression of FL-TRPS1 was lower than that of AML1-TRPS1, the repression of FL-TRPS1 might has been comparable to that of AML1-TRPS1. The Mut M P reporter carrying GATA site mutation was generated by PCR-based mutagenesis using 5′-tctccggcaactgaCaaggattccctgga-3′ as a primer. The substituted nucletotide in the underlined GATA site is capitalized. No activity in the Mut M P reporter suggests that various changes in transcriptional activities observed in this assay, namely activation by GATA-1 and repression by AML1-TRPS1 and TRPS1 per se, are all GATA site dependent.
|
|